☆ 4.7 Article

Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine

JOURNAL OF MEDICAL VIROLOGY (2022)

Related references

Note: Only part of the references are listed.

Review Cardiac & Cardiovascular Systems

COVID-19 and myocarditis: a systematic review and overview of current challenges

Teresa Castiello et al.

Summary: Myocardial inflammation in COVID-19 is documented, with a unclear frequency and prognostic impact of COVID-19-mediated myocarditis. Current evidence suggests myocardial inflammation with different pathophysiology mechanisms. Large multicentre registries may help further elucidate this issue.

HEART FAILURE REVIEWS (2022)

Add to Collection

Letter Critical Care Medicine

Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units

Guillaume Hekimian et al.

CHEST (2021)

Add to Collection

Article Medicine, General & Internal

Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database

Rimple Kaur et al.

International Journal of General Medicine (2021)

Add to Collection

Article

Myocarditis following COVID-19 vaccination

Elisabeth Albert et al.

Radiology Case Reports (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases

Joseph Mansour et al.

Summary: We report two cases of myocarditis, occurring in two young and previously healthy individuals, temporally associated with the second dose of the mRNA-COVID-19 vaccine. Both patients presented with acute chest pain, changes on electrocardiogram (ECG), and elevated serum troponin levels within two days of receiving their second dose. Cardiac magnetic resonance (CMR) findings were consistent with acute myocarditis.

CLINICAL IMAGING (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging

Jitka Starekova et al.

Summary: A case series study found a low prevalence of myocarditis among student athletes recovering from COVID-19 with MRI as a screening tool questioned.

JAMA CARDIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Zijun Wang et al.

Summary: Volunteers who received the Moderna or Pfizer-BioNTech vaccine showed high levels of antibodies and memory B cell responses against SARS-CoV-2, with activity similar to individuals who had recovered from natural infection. However, their efficacy against specific SARS-CoV-2 variants was reduced, indicating a potential need for periodic updates to mRNA vaccines to maintain clinical efficacy.

NATURE (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

Florian Krammer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Pediatrics

Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA a retrospective surveillance study

Joseph Y. Abrams et al.

Summary: Factors such as age, race, clinical symptoms, and laboratory markers were found to be associated with severe outcomes in patients with MIS-C. These findings highlight the importance of early recognition and prompt management for patients with MIS-C.

LANCET CHILD & ADOLESCENT HEALTH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study

Jingxin Li et al.

Summary: The messenger RNA vaccine candidate BNT162b1, encoding the receptor-binding domain of the SARS-CoV-2 spike protein, showed safety and high levels of humoral and T cell responses in an Asian population, including younger and older Chinese adults. Local reactions and systemic events post-vaccination were generally dose-dependent, transient, and mild to moderate.

NATURE MEDICINE (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19

Javier Bautista Garcia et al.

REVISTA ESPANOLA DE CARDIOLOGIA (2021)

Add to Collection

Review Immunology

US Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines

Diane Gubernot et al.

Summary: The COVID-19 pandemic has led to global collaborative efforts to develop vaccines, with mass vaccination campaigns underway in multiple countries. Monitoring vaccine safety and understanding background incidence rates are crucial for assessing adverse events related to vaccination.

VACCINE (2021)

Add to Collection

Article Emergency Medicine

Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report

Kelsey McLean et al.

Summary: Adolescents and young adults may develop myopericarditis after COVID-19 vaccination, requiring careful monitoring and prompt medical attention. More data is needed to understand this potential association, while also considering the overall benefits of vaccination in combating COVID-19.

ACADEMIC EMERGENCY MEDICINE (2021)

Add to Collection

Article

Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection

Anna Patrignani et al.

Radiology Case Reports (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report

Ammar A. Hasnie et al.

Summary: The case report describes a 22-year-old Caucasian male who developed perimyocarditis after receiving the Moderna vaccine, emphasizing the importance for clinicians to be aware of this rare but significant adverse event.

BMC CARDIOVASCULAR DISORDERS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Myocarditis With COVID-19 mRNA Vaccines

Biykem Bozkurt et al.

Summary: Myocarditis is a rare complication of COVID-19 mRNA vaccines, predominantly affecting young adult and adolescent males, with most patients showing improvement in symptoms. Possible mechanisms include molecular mimicry between viral proteins and self-antigens, dysregulated immune pathways, immune response to mRNA, and dysregulated cytokine expression.

CIRCULATION (2021)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine

Alagarraju Muthukumar et al.

CIRCULATION (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Myocarditis After BNT162b2 and mRNA-1273 Vaccination

Kathryn F. Larson et al.

CIRCULATION (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Myocarditis Temporally Associated With COVID-19 Vaccination

Carolyn M. Rosner et al.

CIRCULATION (2021)

Add to Collection

Review Medicine, General & Internal

Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series

Sawai Singh Rathore et al.

Summary: Myocarditis is a cardiac complication in Covid-19 patients, with symptoms like fever and hypertension. Non-specific findings in electrocardiogram and echocardiogram, and myocardial edema and injury in cardiac magnetic resonance imaging are common. Treatment involves antivirals and corticosteroids.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Add to Collection

Article Medicine, General & Internal

Surveillance for Adverse Events After COVID-19 mRNA Vaccination

Nicola P. Klein et al.

Summary: This study conducted interim analysis of safety surveillance data of mRNA COVID-19 vaccines and found that the incidence of selected serious outcomes within 1-21 days post-vaccination was not significantly higher compared with 22-42 days post-vaccination. Surveillance is ongoing despite wide confidence intervals for many outcomes.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Immunology

Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine

Ori Snapiri et al.

Summary: This study described a group of adolescents who developed perimyocarditis following vaccination with the coronavirus disease 2019 vaccine. All cases were mild and none required cardiovascular or respiratory support, but only long-term follow-up can reveal the true impact. The study calls for more comprehensive data collection on a wider scale to analyze potential adverse reactions.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)

Add to Collection

Article Pediatrics

Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination

Mayme Marshall et al.

Summary: This report presents 7 cases of acute myocarditis or myopericarditis in healthy male adolescents following the second dose of Pfizer-BioNTech COVID-19 vaccination, with patients rapidly recovering their symptoms through treatment with nonsteroidal anti-inflammatory drugs, intravenous immunoglobulin, and corticosteroids. The potential association between vaccine administration and myocarditis requires further monitoring and investigation.

PEDIATRICS (2021)

Add to Collection

Article Immunology

Myocarditis following COVID-19 mRNA vaccination

Saif Abu Mouch et al.

Summary: This study reported six cases of myocarditis occurring shortly after BNT162b2 vaccination, all in young males with mild clinical course. All patients responded to the vaccine, and myocarditis post-BNT162b2 vaccination may be considered an adverse reaction.

VACCINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

Julia W. Gargano et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021

Tegan K. Boehmer et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military

Jay Montgomery et al.

Summary: This study investigated cases of myocarditis occurring in male patients within the US Military Health System after receiving mRNA COVID-19 vaccines between January and April 2021. A total of 23 male patients presented with acute chest pain within 4 days post-vaccination, with elevated troponin levels and findings consistent with myocarditis on imaging. The number of cases observed was higher than expected after a second dose of the vaccine among male military members.

JAMA CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children

Audrey Dionne et al.

Summary: This study reviewed comprehensive cardiac imaging results in children with myocarditis after receiving the BNT162b2 COVID-19 vaccine. Most cases of myocarditis occurred in boys after the second dose, and patients showed mild symptoms in short-term follow-up. Long-term risks of post-vaccination myocarditis remain unknown, necessitating larger studies for vaccination recommendations in this population.

JAMA CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

Han W. Kim et al.

Summary: This study described 7 patients with acute myocarditis, 4 of whom had received mRNA COVID-19 vaccination. All patients presented with severe chest pain, biomarker evidence of myocardial injury, and were hospitalized. Cardiac magnetic resonance imaging findings were typical for myocarditis. Further investigation is needed to determine associations of COVID-19 vaccination and myocarditis.

JAMA CARDIOLOGY (2021)

Add to Collection

Letter Medicine, General & Internal

Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine

Nathan E. Richards et al.

JAMA NETWORK OPEN (2021)

Add to Collection

Review Primary Health Care

Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database

Anasua Deb et al.

Summary: Adverse events related to COVID-19 vaccination, such as myocarditis, should be closely monitored by physicians. As COVID-19 vaccine administration expands, vigilance is needed for the possibility of new adverse events, especially cases with acute immune responses post-vaccination.

JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2021)

Add to Collection

Article Medicine, General & Internal

Cardiac Imaging of Acute Myocarditis Following COVID-9 mRNA Vaccination

In Cheol Kim et al.

Summary: A case of acute myocarditis following COVID-19 vaccination was reported, with the patient recovering well without any adverse events after treatment.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?

Alberto Cereda et al.

ANATOLIAN JOURNAL OF CARDIOLOGY (2021)

Add to Collection

Letter Immunology

Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?

Francesco Caso et al.

AUTOIMMUNITY REVIEWS (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management

Bhurint Siripanthong et al.

HEART RHYTHM (2020)

Add to Collection

Letter Immunology

Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases

Aristo Vojdani et al.

CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Analysis of clinical parameters and echocardiography as predictors of fatal pediatric myocarditis

Yi-Jung Chang et al.

PLOS ONE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

A case of biopsy-proven eosinophilic myocarditis related to tetanus toxoid immunization

Hiroyuki Yamamoto et al.

CARDIOVASCULAR PATHOLOGY (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation Expert Recommendations

Vanessa M. Ferreira et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Characteristics of Clinically Diagnosed Pediatric Myocarditis in a Contemporary Multi-Center Cohort

Ryan J. Butts et al.

PEDIATRIC CARDIOLOGY (2017)

Add to Collection

Review Cardiac & Cardiovascular Systems

Gastrointestinal and Liver Issues in Heart Failure

Varun Sundaram et al.

CIRCULATION (2016)

Add to Collection

Article Medicine, General & Internal

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

David Moher et al.

SYSTEMATIC REVIEWS (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Long-Term Follow-Up of Biopsy-Proven Viral Myocarditis Predictors of Mortality and Incomplete Recovery

Stefan Gruen et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

Add to Collection

Article Pediatrics

Clinical Presentation of Pediatric Myocarditis in Taiwan

Hsiang-Ju Hsiao et al.

PEDIATRICS AND NEONATOLOGY (2011)

Add to Collection

Review Anesthesiology

Venous function and central venous pressure - A physiologic story

Simon Gelman

ANESTHESIOLOGY (2008)

Add to Collection

Review Cardiac & Cardiovascular Systems

The importance of the gastrointestinal system in the pathogenesis of heart failure

A Krack et al.

EUROPEAN HEART JOURNAL (2005)

Add to Collection

Article Immunology

Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA

K Karikó et al.

IMMUNITY (2005)

Add to Collection

Article Medicine, General & Internal

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

GH Bardy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection

Article Medicine, General & Internal

The endotoxin-lipoprotein hypothesis

M Rauchhaus et al.

LANCET (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.